Correction: Clinical management and burden of cytomegalovirus in D+/R-Kidney transplant recipients in Canada

John Gill; Andrew A. House; Zain Chagla; Jean Tchervenkov; S. Joseph Kim; Amanda Vinson; Carlos Cervera; Paul A. Keown; Sonia Lai Wing Sun; Christina Khoury; Christiane Ghakis

PMC · DOI:10.3389/fimmu.2025.1712602·October 14, 2025

Correction: Clinical management and burden of cytomegalovirus in D+/R-Kidney transplant recipients in Canada

John Gill, Andrew A. House, Zain Chagla, Jean Tchervenkov, S. Joseph Kim, Amanda Vinson, Carlos Cervera, Paul A. Keown, Sonia Lai Wing Sun, Christina Khoury, Christiane Ghakis

PDF

Open Access

Abstract

Linked entities

Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.

Diseases1

cytomegalovirus

Figures1

Click any figure to enlarge with its caption.

Keywords

cytomegaloviruskidney transplantationantiviral prophylaxis and treatmentimmunosuppressionsuperinfectionleukopeniahospitalizationgraft failure

Peer Reviews

No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.

Videos

No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.

Taxonomy

TopicsCytomegalovirus and herpesvirus research · Renal Transplantation Outcomes and Treatments

Full text

There was a mistake in Figure 2 as published. The X axis legend was incorrect and should read: “Days from transplant to onset of the 1st episode of myelotoxicity”. The corrected Figure 2 appears below.

The original version of this article has been updated.